CORRELATION OF ANTI-FACTOR XA ACTIVITY VALUE, PROTHROMBIN TIME, AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PATIENTS TREATED WITH FACTOR XA INHIBITORS

被引：0
|
作者：
Ono, Ryohei
Fukushima, Kenichi
Takahashi, Hidehisa
Hori, Yasuhiko
Kobayashi, Yoshio
机构：
[1] Chiba Univ, Grad Sch Med, Chiba, Japan
[2] Matsudo City Gen Hosp, Matsudo, Chiba, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1762-007
引用
收藏
页码：2109 / 2109
页数：1
相关论文
共 50 条
  • [1] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ono, Ryohei
    Nishimura, Kazutaka
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Fukushima, Kenichi
    Kobayashi, Yoshio
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (02) : 323 - 336
  • [2] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ryohei Ono
    Kazutaka Nishimura
    Hidehisa Takahashi
    Yasuhiko Hori
    Kenichi Fukushima
    Yoshio Kobayashi
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 323 - 336
  • [3] Distribution of Anti-Factor Xa Activity Value, Prothrombin Time, and Activated Partial Thromboplastin Time in Patients Treated With Factor Xa Inhibitors
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    [J]. CIRCULATION, 2022, 146
  • [4] The Distribution of Anti-factor Xa Activity Values, Prothrombin Time and Activated Partial Thromboplastin Time Assessed at Multiple Points in Patients on Edoxaban Therapy
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa R.
    Hori, Yasuhiko
    Kobayashi, Yoshio
    [J]. CIRCULATION, 2020, 142
  • [5] ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR HEPARIN INFUSION MONITORING
    Jung, Sul
    Choi, Austin
    Lepore, Mark
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [6] Lack of Inter-Laboratory Agreement in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa Activity and the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time
    Toulon, Pierre
    Smahi, Motalib
    De Pooter, Neila
    Zereg, Elamine
    [J]. BLOOD, 2017, 130
  • [7] THE CORRELATIONS BETWEEN ANTI-FACTOR XA ACTIVITY VALUES AND PROTHROMBIN TIME/ACTIVATED PARTIAL THROMBOPLASTIN TIME AT PEAK AND TROUGH TIMES IN PATIENTS ON DIRECT ORAL ANTICOAGULANTS THERAPY
    Ono, Ryohei
    Fukushima, Kenichi
    Yamashita, Daichi
    Takahashi, Hidehisa
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2107 - 2107
  • [8] IMPROVING CLINICAL DECISION MAKING FOR HEPARINIZED PATIENTS WITH DISCORDANT ANTI-FACTOR XA ACTIVITY AND ACTIVATED PARTIAL THROMBOPLASTIN TIME.
    Gombar, Saurabh
    Krishnan, Anandi
    Zehnder, James
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 40 - 40
  • [9] Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support
    Adatya, Sirtaz
    Uriel, Nir
    Yarmohammadi, Hirad
    Holley, Christopher T.
    Feng, Amy
    Roy, Samit S.
    Reding, Mark T.
    John, Ranjit
    Eckman, Peter
    Zantek, Nicole D.
    [J]. JACC-HEART FAILURE, 2015, 3 (04) : 314 - 322
  • [10] Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time?
    Monteagudo-Vela, Maria
    Bowles, Christopher
    Raj, Binu
    Robinson, Derek
    Simon, Andre
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 34 (02) : 322 - 325
12345